Angiosarcoma of the breast gland: molecular genetic profile, diagnosis and treatment-Reference-Cited by-同舟云学术

Angiosarcoma of the breast gland: molecular genetic profile, diagnosis and treatment

Published:2024-09-12 Issue:3 Volume:16 Page:55-60
ISSN:2782-3687
Container-title:Bone and soft tissue sarcomas, tumors of the skin
language:
Short-container-title:jour

Author:

Lyubchenko L. N.¹^ORCID,Saribekyan E. K.²,Bosieva A. R.³^ORCID,Zikiryakhodzhaev A. D.⁴^ORCID,Buchkin G. L.⁵,Zamaldinov N. D.²,Fedenko A. A.²^ORCID

Affiliation:

1. N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

2. P.A. Herzen Moscow Research Oncology Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

3. P.A. Herzen Moscow Research Oncology Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia; 3Russian Peoples’ Friendship University

4. P.A. Herzen Moscow Research Oncology Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia; Russian Peoples’ Friendship University; Sechenov University, Ministry of Health of Russia

5. Sechenov University, Ministry of Health of Russia

Abstract

Angiosarcoma is a rare, aggressive tumor arising from the endothelial cells of blood vessels that can affect internal organs, but the most common location is the skin. The article presents current data on the molecular genetic profile, diagnosis and treatment of primary and secondary angiosarcomas of the breast. A search for relevant sources was carried out in the PubMed, Cochrane Library and eLibrary systems, publications from 2012 to 2023 were examined, 29 of which were used to write this review.no standard treatment guidelines, and the optimal approach remains surgical resection to achieve negative resection margins. The role of neoadjuvant, adjuvant chemotherapy and radiotherapy remains controversial.

Publisher

Publishing House ABV Press

Reference30 articles.

1. Saribekyan E.K., Bosieva A.R., Medvedev S.V. et al. Postradiative angiosarcoma of the breast: a rare clinical case. Zlokachestvennye opukholi = Malignant Tumors 2023;13(2):7. (In Russ.). DOI: 10.18027/2224-5057-2023-13-2-7

2. Smith T.L., Morris C.G., Mendenhall N.P. Angiosarcoma after breastconserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART). Acta Oncol 2014;53(2):235–41. DOI: 10.3109/0284186X.2013.819117

3. Ghareeb E.R., Bhargava R., Vargo J.A. et al. Primary and radiationinduced breast angiosarcoma: clinicopathologic predictors of outcomes and the impact of adjuvant radiation therapy. Am J Clin Oncol 2016;39(5):463–7. DOI: 10.1097/COC.0000000000000077

4. Fedenko A.A., Konev A.A., Anurova O.A. et al. Angiosarcomas. Sarkomy kostei, miagkikh tkanei i opukholi kozhi = Bone and Soft Tissue Sarcomas, Tumors of the Skin 2013;1:24–41. (In Russ.).

5. Mantilla J.G., Koenigsberg T., Reig B. et al. Core biopsy of vascular neoplasms of the breast: pathologic features, imaging, and clinical findings. Am J Surg Pathol 2016;40(10):1424–34. DOI: 10.1097/PAS.0000000000000668